FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155296989> ?p ?o ?g. }

• W2155296989 endingPage "160" @default.
• W2155296989 startingPage "154" @default.
• W2155296989 abstract "Iron chelating agents are essential for treating iron overload in diseases such as β-thalassemia and are potentially useful for therapy in non-iron overload conditions, including free radical mediated tissue injury. Deferoxamine (DFO), the only drug available for iron chelation therapy, has a number of disadvantages (e.g., lack of intestinal absorption and high cost). The tridentate chelator pyridoxal isonicotinoyl hydrazone (PIH) has high iron chelation efficacy in vitro and in vivo with high selectivity and affinity for iron. It is relatively non-toxic, economical to synthesize and orally effective. We previously demonstrated that submillimolar levels of PIH and some of its analogues inhibit lipid peroxidation, ascorbate oxidation, 2-deoxyribose degradation, plasmid DNA strand breaks and 5,5-dimethylpyrroline-N-oxide (DMPO) hydroxylation mediated by either Fe(II) plus H2O2 or Fe(III)–EDTA plus ascorbate. To further characterize the mechanism of PIH action, we studied the effects of PIH and some of its analogues on the degradation of 2-deoxyribose induced by Fe(III)–EDTA plus ascorbate. Compared with hydroxyl radical scavengers (DMSO, salicylate and mannitol), PIH was about two orders of magnitude more active in protecting 2-deoxyribose from degradation, which was comparable with some of its analogues and DFO. Competition experiments using two different concentrations of 2-deoxyribose (15 vs. 1.5 mM) revealed that hydroxyl radical scavengers (at 20 or 60 mM) were significantly less effective in preventing degradation of 2-deoxyribose at 15 mM than 2-deoxyribose at 1.5 mM. In contrast, 400 μM PIH was equally effective in preventing degradation of both 15 mM and 1.5 mM 2-deoxyribose. At a fixed Fe(III) concentration, increasing the concentration of ligands (either EDTA or NTA) caused a significant reduction in the protective effect of PIH towards 2-deoxyribose degradation. We also observed that PIH and DFO prevent 2-deoxyribose degradation induced by hypoxanthine, xanthine oxidase and Fe(III)–EDTA. The efficacy of PIH or DFO was inversely related to the EDTA concentration. Taken together, these results indicate that PIH (and its analogues) works by a mechanism different than the hydroxyl radical scavengers. It is likely that PIH removes Fe(III) from the chelates (either Fe(III)–EDTA or Fe(III)–NTA) and forms a Fe(III)–PIH2 complex that does not catalyze oxyradical formation." @default.
• W2155296989 created "2016-06-24" @default.
• W2155296989 creator A5056211046 @default.
• W2155296989 creator A5069589963 @default.
• W2155296989 creator A5082467121 @default.
• W2155296989 date "2000-10-01" @default.
• W2155296989 modified "2023-10-17" @default.
• W2155296989 title "The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) and its analogues prevent damage to 2-deoxyribose mediated by ferric iron plus ascorbate" @default.
• W2155296989 cites W1497514444 @default.
• W2155296989 cites W1549495570 @default.
• W2155296989 cites W1734082729 @default.
• W2155296989 cites W1882829862 @default.
• W2155296989 cites W1967102030 @default.
• W2155296989 cites W1968616621 @default.
• W2155296989 cites W1992125101 @default.
• W2155296989 cites W1995087031 @default.
• W2155296989 cites W1996848334 @default.
• W2155296989 cites W1999012336 @default.
• W2155296989 cites W2003629225 @default.
• W2155296989 cites W2025917295 @default.
• W2155296989 cites W2025984741 @default.
• W2155296989 cites W2031700878 @default.
• W2155296989 cites W2033985750 @default.
• W2155296989 cites W2046646032 @default.
• W2155296989 cites W2051496266 @default.
• W2155296989 cites W2055066445 @default.
• W2155296989 cites W2055647248 @default.
• W2155296989 cites W2064519033 @default.
• W2155296989 cites W2065905825 @default.
• W2155296989 cites W2069793435 @default.
• W2155296989 cites W2071353722 @default.
• W2155296989 cites W2071586750 @default.
• W2155296989 cites W2073268419 @default.
• W2155296989 cites W2078319346 @default.
• W2155296989 cites W2080711791 @default.
• W2155296989 cites W2084429638 @default.
• W2155296989 cites W2085979427 @default.
• W2155296989 cites W2086565021 @default.
• W2155296989 cites W2125629693 @default.
• W2155296989 cites W2129543544 @default.
• W2155296989 cites W2167226839 @default.
• W2155296989 cites W2170247657 @default.
• W2155296989 cites W2234660551 @default.
• W2155296989 cites W2460084260 @default.
• W2155296989 cites W4254194852 @default.
• W2155296989 doi "https://doi.org/10.1016/s0304-4165(00)00115-x" @default.
• W2155296989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11042379" @default.
• W2155296989 hasPublicationYear "2000" @default.
• W2155296989 type Work @default.
• W2155296989 sameAs 2155296989 @default.
• W2155296989 citedByCount "41" @default.
• W2155296989 countsByYear W21552969892012 @default.
• W2155296989 countsByYear W21552969892013 @default.
• W2155296989 countsByYear W21552969892015 @default.
• W2155296989 countsByYear W21552969892017 @default.
• W2155296989 countsByYear W21552969892018 @default.
• W2155296989 countsByYear W21552969892019 @default.
• W2155296989 countsByYear W21552969892021 @default.
• W2155296989 crossrefType "journal-article" @default.
• W2155296989 hasAuthorship W2155296989A5056211046 @default.
• W2155296989 hasAuthorship W2155296989A5069589963 @default.
• W2155296989 hasAuthorship W2155296989A5082467121 @default.
• W2155296989 hasConcept C126322002 @default.
• W2155296989 hasConcept C139066938 @default.
• W2155296989 hasConcept C155647269 @default.
• W2155296989 hasConcept C178790620 @default.
• W2155296989 hasConcept C185592680 @default.
• W2155296989 hasConcept C197404232 @default.
• W2155296989 hasConcept C24107716 @default.
• W2155296989 hasConcept C2776672577 @default.
• W2155296989 hasConcept C2776778087 @default.
• W2155296989 hasConcept C2777709666 @default.
• W2155296989 hasConcept C2777799968 @default.
• W2155296989 hasConcept C2781053155 @default.
• W2155296989 hasConcept C55493867 @default.
• W2155296989 hasConcept C71924100 @default.
• W2155296989 hasConceptScore W2155296989C126322002 @default.
• W2155296989 hasConceptScore W2155296989C139066938 @default.
• W2155296989 hasConceptScore W2155296989C155647269 @default.
• W2155296989 hasConceptScore W2155296989C178790620 @default.
• W2155296989 hasConceptScore W2155296989C185592680 @default.
• W2155296989 hasConceptScore W2155296989C197404232 @default.
• W2155296989 hasConceptScore W2155296989C24107716 @default.
• W2155296989 hasConceptScore W2155296989C2776672577 @default.
• W2155296989 hasConceptScore W2155296989C2776778087 @default.
• W2155296989 hasConceptScore W2155296989C2777709666 @default.
• W2155296989 hasConceptScore W2155296989C2777799968 @default.
• W2155296989 hasConceptScore W2155296989C2781053155 @default.
• W2155296989 hasConceptScore W2155296989C55493867 @default.
• W2155296989 hasConceptScore W2155296989C71924100 @default.
• W2155296989 hasIssue "2-3" @default.
• W2155296989 hasLocation W21552969891 @default.
• W2155296989 hasLocation W21552969892 @default.
• W2155296989 hasOpenAccess W2155296989 @default.
• W2155296989 hasPrimaryLocation W21552969891 @default.
• W2155296989 hasRelatedWork W2087600599 @default.
• W2155296989 hasRelatedWork W2091974000 @default.
• W2155296989 hasRelatedWork W2168963946 @default.

• next